Health

Greater China Media & Entertainment Corp. Subsidiary Provides Services for China Guardian Auctions

BEIJING, April 1 /Xinhua-PRNewswire/ -- Greater China Media & Entertainment Corporation (OTC Bulletin Board: GCME - News), an integrated professional media and entertainment company, announces that its subsidiary, Racemind HuaDing (Racemind), has entered into two service contracts with China Gua...

2008-03-31 20:30 762

China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results

- FY 2007 Revenues Increased 89.39% to $15.91 million. - FY 2007 EBIT Increased 161.57% to $6.08 million. - FY 2007 Net Income was $6.12 million or $0.15 per fully diluted share. - Teleconference to Be Held at 9:00 a.m. EST Today - NEW YORK, March 31 /Xinhua-PRNew...

2008-03-31 18:00 514

Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results

HUBEI PROVINCE, China, April 1 /Xinhua-PRNewswire/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, t...

2008-04-01 04:01 933

Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K

SHANGHAI, China, April 1 /Xinhua-PRNewswire/ -- Linkwell Corporation (Linkwell) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, announced today that it will file a Form 12b-25 with the Securities and Exchange Commission ...

2008-04-01 02:00 811

Landmark Trial ONTARGET(R) Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population

- From ONTARGET(R) it May be Concluded That Telmisartan can Prevent Every 5th Serious Cardiovascular Event - Results of 25,620 Patient Study ONTARGET(R) (ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial) Presented Today at the 57th Annual Scientific Session...

2008-04-01 01:46 666

China Biologic Products Reports Record Fiscal Year 2007 Results

Net Income Before Minority Interest Increased 98.6% Year-Over-Year to $10.2 Million TAIAN CITY, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic,” or “the Company”), one of the leading plasma-based pharmaceutical comp...

2008-03-31 20:00 905

Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease

Late-stage IDENTITY study of once-daily, oral agent is now enrolling patients INDIANAPOLIS, March 31 /Xinhua-PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has announced today the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for...

2008-03-31 16:00 548

First Statin Monotherapy to Achieve Regression of Coronary Atherosclerosis by Angiography in a Major Clinical Study

ASTEROID Studied the Effect of Intensive CRESTOR(TM) Therapy on Atherosclerosis LONDON, March 31 /Xinhua-PRNewswire/ -- CRESTOR(TM) (rosuvastatin) is the only statin to show regression of coronary atherosclerosis in a major clinical study. That result, which was based on intravascular ultraso...

2008-03-31 23:00 542

Aridol(TM) Endorsed by International Olympic Committee

SYDNEY, Australia, March 27 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced that Australian-made Aridol (mannitol) has been included as an approved test by the International Olympic Committee's independent Medical Commission. The approval was contained...

2008-03-28 06:45 689

China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results

- March 31, 2008 at 11:00 a.m. EDT NEW YORK and HAIKOU CITY, China, March 27 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced i...

2008-03-27 04:28 843

Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million

BEIJING and CLAREMONT, Calif., March 26 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced that revenues for the year ended December 31, 2007 were $9,129,779 an increase of 264.2% over $2,506,715 for 2006. Net sales from cont...

2008-03-26 20:00 647

China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results

GUANGZHOU, China, March 26 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supp...

2008-03-26 03:18 1111

DARA BioSciences, Inc. Announces New Officer and Director Appointments

RALEIGH, N.C., March 26 /Xinhua-PRNewswire/ -- DARA BioSciences(TM) (Nasdaq: DARA) announced today the appointment of John Didsbury, Ph.D. as President and Chief Operating Officer. Dr. Didsbury has served as DARA's Chief Scientific Officer since November 2006. Dr. Didsbury previously served as...

2008-03-26 04:55 1066

Sinovac Announces Adjournment of Annual General Meeting

BEIJING, March 25 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that its Annual General Meeting originally scheduled for March 25, 2008 has been adjourned to April 8, 2008. At the March 25, 2008 Annual General Meeting,...

2008-03-25 14:56 832

China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents

BEIJING, March 24 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products and high intensity focused ultrasound tumor t...

2008-03-24 21:00 788

Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China

BEIJING, March 24 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that Mr. Weidong Yin, CEO, Ms. Nan Wang, Vice President, Ms. Helen Yang, International Business Manager, and Ms. Vanessa Wu, Senior Financial Manager will prese...

2008-03-24 20:30 816

China Nepstar Chain Drugstore Announces Dividend

SHENZHEN, China, March 24 /Xinhua-PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared a cash di...

2008-03-24 19:00 738

'Silent' TB Epidemic Spreads Amid Lack of Laboratory Facilities

MANILA, March 24 /Xinhua-PRNewswire/ -- Inadequate laboratory facilities in Asia and the Pacific are fuelling the spread of drug-resistant strains of tuberculosis (TB), the World Health Organization (WHO) said today. (Logo: http://www.prnasia.com/sa/20061102095006-51.jpg ) M...

2008-03-24 21:06 600

Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals

LAUSANNE, Switzerland, March 20 /Xinhua-PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company, Galderma Laboratories, Inc., has received clearance from the U.S. Federal Trade Commission, throug...

2008-03-20 15:45 714

3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer

SHENYANG, China, March 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) (“3SBio” or the “Company”), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the appointment of Dr. David ...

2008-03-20 04:35 791
1 ... 904905906907908909910 ... 938